Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 11 | $383,138 |
Sells | 5 | $1,090,295 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
17 Apr 2024 20:21 | OTLK | Outlook Therapeutics Inc | SYNTONE VENTURES LLC | 10% | 15 Apr 2024 | Purchase | 714,286 | 0 | 0 | D |
29 Mar 2024 10:39 | OTLK | Outlook Therapeutics Inc | HADDADIN YEZAN MUNTHER | Director | 28 Mar 2024 | Purchase | 1,881.7 | 11.82 | 22,242 | D |
11 Mar 2024 16:43 | OTLK | Outlook Therapeutics Inc | EVANSON JEFF | CHIEF COMMERCIAL OFFICER | 07 Mar 2024 | Purchase | 62,484 | 0.42 | 26,243 | D |
21 Apr 2023 21:05 | OTLK | Outlook Therapeutics Inc | DAGNON TERRY | Chief Operations Officer | 20 Apr 2023 | Sale | 520,000 | 1.135 | 590,200 | D |
24 Jan 2023 20:08 | OTLK | Outlook Therapeutics Inc | EVANSON JEFF | Chief Commercial Officer | 20 Jan 2023 | Sale | 267,000 | 1.11 | 296,370 | D |
19 Jan 2023 20:05 | OTLK | Outlook Therapeutics Inc | EVANSON JEFF | Chief Commercial Officer | 19 Jan 2023 | Sale | 103,255 | 1.22 | 125,971 | D |
19 Jan 2023 20:05 | OTLK | Outlook Therapeutics Inc | EVANSON JEFF | Chief Commercial Officer | 18 Jan 2023 | Sale | 33,738 | 1.25 | 42,172 | D |
19 Jan 2023 20:05 | OTLK | Outlook Therapeutics Inc | EVANSON JEFF | Chief Commercial Officer | 17 Jan 2023 | Sale | 27,162 | 1.31 | 35,582 | D |
11 Oct 2022 17:09 | OTLK | Outlook Therapeutics Inc | SUKHTIAN FAISAL GHIATH | Director | 07 Oct 2022 | Purchase | 30,000 | 1.29 | 38,700 | D |
11 Oct 2022 17:05 | OTLK | Outlook Therapeutics Inc | HADDADIN YEZAN MUNTHER | Director | 07 Oct 2022 | Purchase | 3,600 | 1.27 | 4,572 | D |
11 Oct 2022 17:05 | OTLK | Outlook Therapeutics Inc | HADDADIN YEZAN MUNTHER | Director | 06 Oct 2022 | Purchase | 29,743 | 1.29 | 38,368 | D |
05 Oct 2022 16:43 | OTLK | Outlook Therapeutics Inc | HILZINGER KURT J | Director | 05 Oct 2022 | Purchase | 15,662 | 1.23 | 19,264 | D |
05 Oct 2022 16:43 | OTLK | Outlook Therapeutics Inc | HILZINGER KURT J | Director | 04 Oct 2022 | Purchase | 95,541 | 1.29 | 123,248 | D |
03 Oct 2022 17:19 | OTLK | Outlook Therapeutics Inc | HILZINGER KURT J | Director | 03 Oct 2022 | Purchase | 41,798 | 1.25 | 52,248 | D |
03 Oct 2022 17:19 | OTLK | Outlook Therapeutics Inc | HILZINGER KURT J | Director | 30 Sep 2022 | Purchase | 33,199 | 1.26 | 41,831 | D |
03 Oct 2022 17:19 | OTLK | Outlook Therapeutics Inc | HILZINGER KURT J | Director | 29 Sep 2022 | Purchase | 13,800 | 1.19 | 16,422 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)